BioNexus Gene Lab
BGLC
#11183
Rank
S$3.1 M
Marketcap
S$1.06
Share price
-9.43%
Change (1 day)
-82.58%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): S-$1.39

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is S-$1.39. In 2025 the company made an earnings per share (EPS) of S-$2.07 a decrease over its 2024 EPS that were of S-$1.16.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.39-33.03%
2025S-$2.0779.15%
2024S-$1.16-45.96%
2023S-$2.14260.87%
2022S-$0.59-195.83%
2021S$0.62-66.67%
2020S$1.86-600.17%
2019S-$0.37-1031.69%
2018S$0.03983

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA